| mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability L Schoenmaker, D Witzigmann, JA Kulkarni, R Verbeke, G Kersten, ... International journal of pharmaceutics 601, 120586, 2021 | 1193 | 2021 |
| Identification of formaldehyde-induced modifications in proteins: reactions with model peptides B Metz, GFA Kersten, P Hoogerhout, HF Brugghe, HAM Timmermans, ... Journal of Biological Chemistry 279 (8), 6235-6243, 2004 | 779 | 2004 |
| Current and next generation influenza vaccines: Formulation and production strategies PC Soema, R Kompier, JP Amorij, GFA Kersten European Journal of Pharmaceutics and Biopharmaceutics 94, 251-263, 2015 | 387 | 2015 |
| Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice IM van der Lubben, G Kersten, MM Fretz, C Beuvery, JC Verhoef, ... Vaccine 21 (13-14), 1400-1408, 2003 | 345 | 2003 |
| Buccal and sublingual vaccine delivery H Kraan, H Vrieling, C Czerkinsky, W Jiskoot, G Kersten, JP Amorij Journal of controlled release 190, 580-592, 2014 | 238 | 2014 |
| Identification of formaldehyde-induced modifications in proteins: reactions with insulin B Metz, GFA Kersten, GJE Baart, A de Jong, H Meiring, J ten Hove, ... Bioconjugate chemistry 17 (3), 815-822, 2006 | 224 | 2006 |
| Dissolving microneedle patches for dermal vaccination M Leone, J Mönkäre, JA Bouwstra, G Kersten Pharmaceutical research 34, 2223-2240, 2017 | 220 | 2017 |
| Liposomes and ISCOMS GFA Kersten, DJA Crommelin Vaccine 21 (9-10), 915-920, 2003 | 214 | 2003 |
| Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice Z Ding, FJ Verbaan, M Bivas-Benita, L Bungener, A Huckriede, ... Journal of Controlled Release 136 (1), 71-78, 2009 | 186 | 2009 |
| Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach PC Soema, GJ Willems, W Jiskoot, JP Amorij, GF Kersten European journal of pharmaceutics and biopharmaceutics 94, 427-435, 2015 | 163 | 2015 |
| On the structure of immune-stimulating saponin-lipid complexes (iscoms) GFA Kersten, A Spiekstra, EC Beuvery, DJA Crommelin Biochimica et Biophysica Acta (BBA)-Biomembranes 1062 (2), 165-171, 1991 | 154 | 1991 |
| Towards tailored vaccine delivery: needs, challenges and perspectives JP Amorij, GFA Kersten, V Saluja, WF Tonnis, WLJ Hinrichs, B Slütter, ... Journal of Controlled Release 161 (2), 363-376, 2012 | 153 | 2012 |
| Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays K van der Maaden, R Luttge, PJ Vos, J Bouwstra, G Kersten, I Ploemen Drug delivery and translational research 5, 397-406, 2015 | 115 | 2015 |
| Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations SM Bal, B Slütter, E van Riet, AC Kruithof, Z Ding, GFA Kersten, W Jiskoot, ... Journal of Controlled Release 142 (3), 374-383, 2010 | 113 | 2010 |
| Reduction of animal use in human vaccine quality control: opportunities and problems B Metz, CFM Hendriksen, W Jiskoot, GFA Kersten Vaccine 20 (19-20), 2411-2430, 2002 | 112 | 2002 |
| Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV WAM Bakker, YE Thomassen, AG van’t Oever, J Westdijk, ... Vaccine 29 (41), 7188-7196, 2011 | 107 | 2011 |
| Microneedle-based transcutaneous immunisation in mice with N-trimethyl chitosan adjuvanted diphtheria toxoid formulations SM Bal, Z Ding, GFA Kersten, W Jiskoot, JA Bouwstra Pharmaceutical research 27, 1837-1847, 2010 | 105 | 2010 |
| Physicochemical and immunochemical techniques predict the quality of diphtheria toxoid vaccines B Metz, W Jiskoot, WE Hennink, DJA Crommelin, GFA Kersten Vaccine 22 (2), 156-167, 2003 | 104 | 2003 |
| Novel hollow microneedle technology for depth-controlled microinjection-mediated dermal vaccination: a study with polio vaccine in rats K van der Maaden, SJ Trietsch, H Kraan, EM Varypataki, S Romeijn, ... Pharmaceutical research 31, 1846-1854, 2014 | 103 | 2014 |
| Stability of mono-and trivalent meningococcal outer membrane vesicle vaccines C Arigita, W Jiskoot, J Westdijk, C van Ingen, WE Hennink, ... Vaccine 22 (5-6), 629-642, 2004 | 98 | 2004 |
